Zevra Therapeutics, Inc. ZVRA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $124.22M+235% | $83.23M+179% | $35.33M+139% | $2.64M+104% | -$91.99M-86.0% | ||
| $2.77M-57.2% | $4.05M-36.5% | $5.34M-3.4% | $6.57M+65.2% | $6.48M+160% | ||
| $12.62M-20.6% | $12.63M-15.2% | $12.37M+0.1% | $15.73M+107% | $15.9M+123% | ||
| —— | —— | —— | -$46.21M+17.6% | -$61.72M-35.2% | ||
| $802K+710% | $866K— | $866K+1,103% | $312K+27.9% | $99K-62.9% | ||
| —— | —— | —— | -$14.35M— | -$26.41M— | ||
| $60.09M— | $0— | —— | —— | —— | ||
| -$42.35M-151% | $12.06M-85.3% | $10.31M-88.1% | $68.55M+43.4% | $82.5M+147% | ||
| $58.26M+1,157% | $28.62M+409% | $400K-96.3% | $8.45M+131% | -$5.51M-306% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Zevra Therapeutics, Inc. generate?
- Zevra Therapeutics, Inc. (ZVRA) generated -$21.9M in operating cash flow over the trailing twelve months.
- What is Zevra Therapeutics, Inc.'s free cash flow?
- After $802.0K of capital expenditures, Zevra Therapeutics, Inc.'s free cash flow was -$22.3M over the trailing twelve months, up 68.0% year over year.
- Where does Zevra Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Zevra Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
